REG - Oxford Biomedica PLC - Holding(s) in Company

Oxford BioMedicaAnnouncement

03/06/2019 18:10

RNS Number : 0010B
Oxford Biomedica PLC
03 June 2019
 


TR-1: Standard form for notification of major holdings
 



NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i










1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:


Oxford Biomedica Plc




1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)




Non-UK issuer








2. Reason for the notification (please mark the appropriate box or boxes with an "X")




An acquisition or disposal of voting rights


X




An acquisition or disposal of financial instruments








An event changing the breakdown of voting rights








Other (please specify)iii:








3. Details of person subject to the notification obligationiv




Name


Novo Nordisk Foundation




City and country of registered office (if applicable)


Tuborg Havnevej 19
DK 2900 Hellerup
Denmark




4. Full name of shareholder(s) (if different from 3.)v




Name


Novo Holdings A/S




City and country of registered office (if applicable)


Tuborg Havnevej 19
DK 2900 Hellerup
Denmark




5. Date on which the threshold was crossed or reachedvi:


3 June 2019




6. Date on which issuer notified (DD/MM/YYYY):


3 June 2019




7. Total positions of person(s) subject to the notification obligation








% of voting rights attached to shares (total of 8. A)


% of voting rights through financial instruments

(total of 8.B 1 + 8.B 2)


Total of both in % (8.A + 8.B)


Total number of voting rights of issuervii




Resulting situation on the date on which threshold was crossed or reached


8.7%


0


8.7%


6,568,024




Position of previous notification (if
applicable)




























 



8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii


 




A: Voting rights attached to shares


 




Class/type of

shares
ISIN code (if possible)


Number of voting rightsix


% of voting rights


 




Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)


Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)


Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)


 




GB00BDFBVT43


6,568,024


0


8.7%


0


 
























 
























 




SUBTOTAL 8. A


6,568,024


8.7%


 




 
 




B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))


 




Type of financial instrument


Expiration

datex


Exercise/

Conversion Periodxi


Number of voting rights that may be acquired if the instrument is
exercised/converted.


% of voting rights


 
























 
























 
























 












SUBTOTAL 8. B 1










 




 
 




B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))


 




Type of financial instrument


Expiration

datex


Exercise/

Conversion Period xi


Physical or cash
settlementxii


Number of voting rights


% of voting rights


 




























 




























 




























 
















SUBTOTAL 8.B.2










 










9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an "X")


 




Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii


X


 




Full chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)






 




Namexv


% of voting rights if it equals or is higher than the notifiable threshold


% of voting rights through financial instruments if it equals or is higher than the notifiable threshold


Total of both if it equals or is higher than the notifiable threshold


 




















 




















 




















 




















 




















 








 




10. In case of proxy voting, please identify:


 




Name of the proxy holder






 




The number and % of voting rights held






 




The date until which the voting rights will be held






 








 




11. Additional informationxvi


 




The qualifying instruments are held by Novo Holdings A/S, the holding company in the Novo Group.  Novo Holdings A/S is wholly owned by the Novo Nordisk Foundation.


 





















 
 



Place of completion


London, United Kingdom




Date of completion


3 June 2019



 



Contact name:


Stuart Paynter




Contact telephone number:


01865 783000



 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUORBRKOANRAR